Study provides guidance on drug holidays from popular osteoporosis treatments

Doctors commonly recommend drug holidays, or breaks, from certain osteoporosis drugs due to the risks associated with these treatments. Yet little has been known about the ideal duration of the holidays and how best to manage patients during this time.

This popular class of medications, known as bisphosphonates, has been shown to cause fractures in the thigh bones and tissue decay in the . The American Association of Clinical Endocrinologists recommends a drug holiday or break from these treatments after four to five years of density stability if osteoporosis is moderate and after 10 years of stability if is high.

However, new research from Loyola University Health System reveals that should resume treatment if they develop a fracture, have a decline in bone strength or an early rise in signs indicative of increased fracture risk. Researchers also found that and those with very low bone strength should be closely followed during a break from treatment. These findings were published in the latest issue of Endocrine Practice.

"This study provides some guidance about what to do during drug holidays and how long they should last," said Pauline Camacho, MD, study investigator and director of the Loyola University Osteoporosis & Metabolic Bone Disease Center. "The results highlight groups who are at risk for fractures during drug holidays and recommendations on when to resume treatment."

Loyola researchers evaluated 209 patients who started a drug holiday from bisphosphonates. Eleven patients (5.2 percent) developed fractures and all patients had a significant increase in bone-specific alkaline phosphatase at six months. This level was more pronounced in patients who developed a fracture. While there was no significant change in the bone mineral density of the lumbar spine, there was a statistically significant decline in the femoral neck bone mineral density.

"These findings will help us continue to refine the current practice of drug holidays to better manage patients with osteoporosis," Dr. Camacho said.

add to favorites email to friend print save as pdf

Related Stories

Taking a break from osteoporosis drugs can protect bones

Nov 18, 2010

Taking time off from certain osteoporosis drugs may be beneficial to bone health, according to a study conducted at Loyola University Health System. Researchers found that bone density remained stable for three years in patients ...

Osteoporosis drugs compared for side effects, efficacy

Nov 28, 2013

A study comparing the efficacy and tolerability of two popular osteoporosis drugs, denosumab and zoledronic acid, found that denosumab had a significantly greater effect on increasing spine bone mineral density and zoledronic ...

Alendronate reduces adjacent-level vertebral fractures

Dec 30, 2013

(HealthDay)—For females with osteoporosis, the rate of adjacent-level vertebral fractures is relatively low, with reduced odds with bisphosphonate therapy, according to a study published in the Dec. 1 issue ...

Recommended for you

UN says Syria vaccine deaths was an NGO 'mistake'

8 hours ago

The recent deaths of Syrian children after receiving measles vaccinations was the result of a "mistake" by a non-governmental partner who mixed in a muscle relaxant meant for anesthesia, a spokesman for the U.N. secretary-general ...

First US child dies from enterovirus D68

9 hours ago

A child in the northeastern US state of Rhode Island has become the first to die from an ongoing outbreak of a respiratory virus, enterovirus D68, health officials said Wednesday.

US Ebola patient had contact with kids: governor

9 hours ago

A man who was diagnosed with Ebola in virus in Texas came in contact with young children, and experts are monitoring them for any signs of disease, governor Rick Perry said Wednesday.

UN worker dies of suspected Ebola in Liberia

10 hours ago

The United Nations mission in Liberia announced on Wednesday the first suspected victim among its employees of the deadly Ebola epidemic ravaging the impoverished west African nation.

User comments